Agree 100%. This is why I get worried when NP talks of only accepting the best deal for shareholders. Due to a failure to plan and reduce the financial risk of the company in earlier stages - right or wrong - the company is now in a position where shareholders have been diluted nearly 40% (not counting warrants!) year-over-year (https://ycharts.com/companies/CYDY/shares_outstanding), and we're in no better financial condition than we previously were. The often-discussed HIV commercialization deal would be a welcome change, and would provide some non-dilutive funding and a roadmap to what the financial future looks like. Even if it's not perfect, it's better than what we've been doing. And importantly - perfect is probably unattainable for a company sitting on the OTC with no money, regardless of how good of a product it owns.

This is why I lost my mind when NP paused the deal. He better come with one of two things tomorrow: a deal, or overwhelming evidence that something better is coming. And not just "soon" or "any day now".